test

Ron Rosenstraus

@Eversept Partners, Lp

Latest period2024 - Q3ReportedManaged Assets$1.46BTotal holdings67
Assets growth rate-0.03%Assets growth rate (2-Q avg)-1.3%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Eversept Partners, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 67 positions.

Assets under management

The assets under management (AUM) of Eversept Partners, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.46B in assets, with a quarterly growth rate of -0.03% and a 2-quarter average growth rate of -1.3%. The portfolio is managed by Ron Rosenstraus, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
NVONovo-nordisk A S
Recent Activity
Exited
0%
$20.976M
146,956 shares@ $142.74 avg price
LLYEli Lilly & Co
Recent Activity
Exited
0%
$19.224M
21,233 shares@ $905.39 avg price
ARGXArgenx Se
Recent Activity
Exited
0%
$14.876M
34,593 shares@ $430.05 avg price
XBISpdr Ser Tr
Recent Activity
Exited
0%
$9.271M
100,000 shares@ $92.71 avg price
VKTXViking Therapeutics Inc
Recent Activity
Exited
0%
$7.341M
138,489 shares@ $53.02 avg price
PCVXVaxcyte Inc
Recent Activity
Exited
0%
$7.256M
96,089 shares@ $75.51 avg price
CYTKCytokinetics Inc
Recent Activity
Exited
0%
$6.874M
126,877 shares@ $54.19 avg price
OSCROscar Health Inc
Recent Activity
Exited
0%
$4.918M
310,893 shares@ $15.82 avg price
CERECerevel Therapeutics Hldng I
Recent Activity
Exited
0%
$4.498M
110,010 shares@ $40.9 avg price
MYGNMyriad Genetics Inc
Recent Activity
Exited
0%
$4.451M
181,961 shares@ $24.46 avg price